According to the UK Government, around 90% of adults with Type 2 Diabetes are considered to be overweight or have obesity. Obesity can lead to numerous health issues in the future and for people with Type 2 Diabetes, the management of weight loss can be particularly important. This study hopes to help those people.
We’re investigating the study treatment’s effectiveness at managing weight loss in type 2 diabetic patients who are overweight or have obesity
This study is open to anyone over the age of 18 who:
- Has a BMI of 27 or over
- Has a diagnosis of Type 2 Diabetes
Other inclusion / exclusion criteria will apply and this will be discussed with you by one of our research team over the phone.
Your participation in this study will last for just under 2 years and will involve receiving the study treatment, or a placebo, once a week throughout the study.
Your participation will also involve regular visits to our clinic throughout the course of the study
You will receive compensation for your study related time and activities, such as visits to our clinic.
Participation in clinical trials provides access to innovative and potentially life-saving treatments. It also contributes to medical research, benefiting both current and future healthcare outcomes. It provides cutting-edge medical care under professional supervision and empowers individuals to contribute to the well-being of society. However, participants should carefully weigh up the risks and benefits and seek advice from their doctor before taking part in a trial.
